Accelerating Adoption of Digital Pathology through Patient Centric Solutions

Digital pathology involves scanning glass slides of tumour biopsies as high-resolution digital images, which can then be analysed with diagnostic 'scoring' software. Such algorithms are aiding and accelerating the work of Australia's highly experienced, expert pathologists.

Roche invited three well-respected Australian medical professionals - a breast pathologist, a tumour pathologist and a medical scientist/PhD student, to contribute to this discussion. All have a deep interest in digital pathology and its application to improving patient care.

It was our great pleasure to host pathology experts for an insightful discussion on how Australian laboratories can accelerate the adoption of digital pathology through solutions that put patient care at the centre.

In 2021, A/Prof Nirmala Pathmanathan and Dr. Cameron Snell went head-to-head in a live webinar comparing manual and digitally assisted HER2 Dual ISH scoring, and the results were promising. The results subsequently led to Dr. Cameron Snell and Madeline Gough’s clinical study on the application of digital pathology and image analysis algorithms for analysing challenging breast tissue samples.

So where is Australia now, and where are we heading on the Digital Pathology journey?

On Wednesday 6 December 2023, we invited back A/Prof Nirmala Pathmanathan, Dr. Cameron Snell and PhD Candidate Madeline Gough to bring us up to speed on this emerging technology.

View the recordings below:

A/Prof. Nirmala Patmanathan

Clinical associate professor with the University of Sydney, Faculty of Medicine and Health

Dr. Cameron Snell BMedSc MBBS (Melb.) DPhil (Oxon.) FRCPA
PhD Candidate Madeline Gough
About the presenters

About the presenters

Nirmala Pathmanathan is an anatomical pathologist with expertise in breast diseases. She has been the Service Director of the Westmead Breast Cancer Institute in Sydney (a multidisciplinary breast diagnostic and treatment centre servicing Western Sydney) since 2012 and a senior breast pathologist with Douglass Hanly Moir Pathology in Sydney. She is a Clinical Associate Professor with the University of Sydney, Faculty of Medicine and Health as well as the director of the BreastScreen Programme for Sydney West and also chair of the BreastScreen NSW pathology group.

Dr. Cameron Snell is Head of Anatomical Pathology at Peter MacCallum Cancer Centre, Melbourne. He is involved in teaching and research with a particular interest in the digital quantification of slide-based biomarkers and using morphology to personalise cancer care. He has an active interest in quality and sits on the board of professional practice and quality at the RCPA.

Madeline Gough is a Medical Scientist in Anatomical Pathology at Mater Pathology and a final year PhD Candidate with the University of Queensland and Mater Research Institute. She has a particular interest in investigating ways to improve selection of patients for targeted therapies using novel and established biomarkers. Madeline is a recipient of a higher degree research training program scholarship awarded by the University of Queensland Graduate School and a Frank Clair Scholarship.


Let one of our Digital Pathology experts get in touch with you for a detailed discussion.
Form Successfully Submitted!
Thank you for your submission!